Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
07034038
ABSTRACT:
The invention relates to enantiomer (−) of tentoprazole. The inventive enantiomer (−) of tenatoprazole, or (−)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. Said invention can be used for curing digestive pathologies.
REFERENCES:
patent: 5948789 (1999-09-01), Larsson et al.
patent: 6706737 (2004-03-01), Whittle et al.
patent: 0005129 (1979-10-01), None
patent: 0103553 (1984-03-01), None
patent: 0254588 (1988-01-01), None
patent: WO 94/27988 (1994-12-01), None
patent: WO 01/28558 (2001-04-01), None
Kakinoki, abstract only, CA 131:208915, abstract of Methods and Findings in Experimental and Clinical Pharmacology, VOl 21(3), pp 179-187, 1999.
Uchiyama, abstract only, CA 131:139269, Methods and Findings in Experimental and Clinical Pharmacology, VOl 21(2). pp 115-122, 1999.
Uchiyama, abstract only, CA 131:125259, abstract of J of PHarmacy and Pharmacology, vol. 51(4), pp 457-464, 1999.
Jedediah Bateman et al., “Comparison of Pharmacokinetic Properties of Omeprazole and Esomeprazole”, Pharmaceutics 1 (PSCI 423), Apr. 4, 2002.
“Esomeprazole—Proton Pump Inhibitors Revisted”, RGH Pharmacy E-Bulletin, vol. 10 (7): Jun. 16, 2003.
Charbit Suzy
Cohen Avraham
Ficheux Hervé
Homerin Michel
Schutze François
Buchanan & Ingersoll PC
Seaman D. Margaret
Sidem Pharma
LandOfFree
Enantiomer (-) of tenatoprazole and the therapeutic use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomer (-) of tenatoprazole and the therapeutic use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomer (-) of tenatoprazole and the therapeutic use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3588286